Clinical Response Predictive Model for Omalizumab in Moderate-to-Severe Asthma Patients
Objective. Our study aimed to develop a predictive model for evaluating the clinical response of omalizumab treatment in moderate-to-severe asthma patients. Methods. This single-center, prospective study collected patients who meet the diagnostic criteria for moderate-to-severe bronchial asthma set...
Saved in:
Main Authors: | Ruiqi Qian, Lingyi Yang, Xurui Shen, Cheng Chen, Jianan Huang, Xiuqin Zhang, Cuiping Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | International Journal of Clinical Practice |
Online Access: | http://dx.doi.org/10.1155/2024/4651216 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Case of Severe Asthma with Eosinophilic Otitis Media Successfully Treated with Anti-IgE Monoclonal Antibody Omalizumab
by: Azusa Okude, et al.
Published: (2012-01-01) -
The Bee Sting That Was Not: An Unusual Case of Hymenoptera Anaphylaxis Averted in a Patient Treated with Omalizumab for Asthma
by: Evelyn M. Slaughter, et al.
Published: (2014-01-01) -
Efficacy of Omalizumab in Indolent Systemic Mastocytosis
by: Calum Slapnicar, et al.
Published: (2019-01-01) -
The Significance of Eosinophil-to-Lymphocyte Ratio in Predicting Response to Omalizumab Treatment in Patients with Bullous Pemphigoid: A Case Series
by: Gülfem Akin, et al.
Published: (2024-01-01) -
IgE as a predictor to omalizumab response in patients with chronic spontaneous urticaria
by: Luis Felipe Ensina, et al.
Published: (2025-01-01)